AzTrials
AzTrials

Spinal Cord InjuriesGLB-SCI+NCT03874988

Building an Evidence Base for Weight Loss Strategies Among Those With Chronic SCI-The GLB-SCI+

A study testing Enhanced Self-Monitoring, GLB-SCI and GLB-SCI+ in people with Spinal Cord Injuries and Obesity, run by Baylor Research Institute at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study's overarching aim is to follow a systematic approach that incorporates community-based participatory research (CBPR) to develop a multi-component weight loss intervention that may yield significant effects for a chronic SCI sample. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Spinal Cord Injuries, Obesity, Weight Loss
What is being tested?
Enhanced Self-Monitoring, GLB-SCI and GLB-SCI+
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteUnited States
Study dates
1 Jun 2019to 15 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Over 18 years old
  • Have had a spinal cord injury for at least 1 year
  • Overweight as evidenced by BMI > 25
  • Must have sufficient upper arm mobility to engage in exercise
  • Must have access to the internet
  • Must be able to obtain physician signed clearance to participate in a weight management intervention

Who cannot join

  • Cognitive impairment which substantially impairs autonomy (e.g. mental retardation)
  • Medical issues for which exercise is contraindicated such as uncontrolled hypertension or coronary heart disease,
  • Pregnancy
  • Not fluent in English
  • Presence of grade 3 or 4 pressure ulcer
  • Previously diagnosed eating disorder

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Baylor Scott & White Institute for Rehabilitation - Dallas

    Dallas, Texas, 75246

Other trials in United States

About this study

This study's overarching aim is to follow a systematic approach that incorporates community-based participatory research (CBPR) to develop a multi-component weight loss intervention that may yield significant effects for a chronic SCI sample. The approach is to obtain data on the 3 unique strategies (prepackaged/portion-controlled meals; enhanced self-monitoring; the GLB-SCI) to inform design of an empirically supported and consumer-validated multicomponent intervention program, that combines the best of the 3 approaches into one unique intervention, the GLB SCI+. Based on the investigators' prior experience with adapting and delivering the GLB AIM (a lifestyle intervention previously adapted for those with impaired mobility), interim findings, existing literature, and consumer feedback, they hypothesize that these 3 unique strategies may confer individualized benefits to people with SCI given their complex disability-related barriers to weight loss.

Being tested
Portion-Controlled Meals, Enhanced Self-Monitoring, GLB-SCI, GLB-SCI+
Medical subject headings
Spinal Cord Injuries, Obesity, Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Portion-Controlled MealsBehavioural

    Participants will receive portion-controlled meals with the aim of encouraging weight loss and healthier eating.

  • Enhanced Self-MonitoringBehavioural

    Participants will be encouraged to track their physical activity, food intake, and weight using technology that will be provided as part of the study.

  • GLB-SCIBehavioural

    Participants will take part in a lifestyle intervention program (tailored for spinal cord injury needs) that encourages steady weight loss through increased physical activity and healthier diet patterns.

  • GLB-SCI+Behavioural

    Participants will receive a combination of the prior interventions studied, with the goal of showing that a multi-component intervention will be the most effective in encouraging weight loss among participants with a spinal cord injury.

Study groups in NCT03874988
Study groupRoleWhat they receive
Portion-Controlled MealsExperimentalParticipants will receive prepackaged food, delivered biweekly to their home over the course of 13 weeks, with costs covered by the grant. Depending on their calorie goals, participants will drink and eat a mix of shakes and entrees each day, plus up to five fruits and vegetables. HMR entrees and shakes are formulated to provide recommended levels of macronutrients, vitamins, sodium, fat, cholesterol and fiber and fortified to meet at least 100% of the recommended daily allowance for essential vitamins and minerals.
Receives: Behavioral: Portion-Controlled Meals
Enhanced Self-MonitoringExperimentalParticipants will be encouraged to self-monitor 4 specific behaviors daily: 1) measuring their food; 2) measuring their physical activity; 3) recording their food, drink, and physical activity; and 4) monitoring their weight. To achieve this aim, participants will attend a single group-based educational session at baseline during which they will be provided the self-monitoring equipment (scale and Garmin vivofit) and receive training about how to use the Lilypad scale and smartphone food tracking app.
Receives: Behavioral: Enhanced Self-Monitoring
GLB-SCIExperimentalThe content and delivery format of the developed GLB SCI lifestyle intervention program is subject to change based on guidance of the SCI Consumer Group. Therefore, this section provides a general description of the GLB AIM (lifestyle intervention program adapted for impaired mobility). The content of the GLB AIM core meetings include a mix of in-person (4) and telephone (9) sessions. The initial meeting is conducted in person, with one in-person sessions delivered each month, and the intervening weeks delivered by telephone. To achieve weight loss, participants will be encouraged to follow daily calorie and fat gram goals to achieve a .5 to 1 pound weight loss over the 13 weeks. Participants will also be encouraged to gradually increase their physical activity to ultimately achieve 150 weekly minutes.
Receives: Behavioral: GLB-SCI
GLB-SCI+ExperimentalThe final multicomponent GLB SCI+ will include combining specific intervention strategies identified from the previous 3 interventions as effective and usable. If all 3 strategies yield evidence in support of being included, the combined intervention would encompass (1) providing prepackaged foods for a specified period of time to facilitate greater initial weight loss, (2) encouraging enhanced self-monitoring of food, physical activity, and weight using devices and apps along with social support, and (3) delivering the further adapted GLB SCI in a group-based format to teach skills helpful in making lifestyle changes.
Receives: Behavioral: GLB-SCI+

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in weight

    Change in weight (pounds) will be measured after each 13-week intervention.

    Measured: Approximately every 13 weeks through study completion, expected to be 3 years.

  2. Change in physical activity level

    Change in self-reported physical activity (minutes per week) will be measured after each 13-week intervention to assess whether the intervention effectively encouraged greater levels of physical activity.

    Measured: Approximately every 13 weeks through study completion, expected to be 3 years.

  3. Self-efficacy

    Self-efficacy will be measured through changes in the Self-Rated Abilities for Health Practices Scale from baseline to post-intervention. The questionnaire contains 28 items that are on a 5-point scale. It was designed to measure a person's perception of his/her own ability to practice "healthy" behaviors and has 4 sub-scales with 7 items each: Exercise, Nutrition, Responsible Health Practice, and Psychological Well Being. Ratings for each subscale are summed to yield subscale scores and subscale scores are summed to obtain a total score. Higher scores indicate greater confidence in one's ability to perform health practices and total scores range from 0-112.

    Measured: Approximately every 13 weeks through study completion, expected to be 3 years.

  4. Function/Quality of Life

    Changes in self-reported levels of function and quality of life will be assessed through the LIFE-H survey, given before and after each intervention. The Assessment of Life Habits (LIFE-H) assesses a person's self-reported difficulty with and need for assistance performing tasks associated with activities of daily living (ADL) and social roles. The version used for this study covers 6 ADL categories: nutrition, fitness, personal care, communication, residence, mobility and 6 social role categories: responsibility, interpersonal relations, community, education, employment, recreation. Scoring is based on respondent rating of level of accomplishment (No difficulty to Not accomplished) combined with the type of assistance (if any) used to perform these tasks. Scores range from 9 to 0, with higher scores indicating less difficulty.

    Measured: Approximately every 13 weeks through study completion, expected to be 3 years.

Secondary outcomes (4)
  1. Change in waist circumference

    Participants will have their waist circumference measured before and after each intervention to assess the level of change, if any.

    Measured: Approximately every 13 weeks through study completion, expected to be 3 years.

  2. Change in blood pressure (systolic and diastolic)

    Participants will have their blood pressure measured before and after each intervention to assess the level of change, if any.

    Measured: Approximately every 13 weeks through study completion, expected to be 3 years.

  3. Change in hemoglobin A1c level

    Participants will have their hemoglobin A1c measured before and after each intervention assess the level of change, if any.

    Measured: Approximately every 13 weeks through study completion, expected to be 3 years.

  4. Change in motivation for weight-loss

    Participants will have their levels of motivation assessed before and after each intervention with the Treatment Self-Regulation Questionnaire. The 18-item Treatment Self-Regulation Questionnaire is derived from self-determination theory and yields 2 subscales: autonomous regulation (or intrinsic motivation) and controlled regulation (or extrinsic motivation). Responses are provided on a 7-point Likert type scale ranging from 1 'not at all true' to 7 'very true,' and includes the option of "not applicable." Autonomous Regulation scores are obtained by averaging questions 3, 4, 9, 13, 17, 18 and Controlled Regulation scores are obtained by averaging questions 1, 2, 5, 6, 7, 8, 10, 11, 12, 14, 15, 16. Higher scores indicate higher levels of motivation. Higher scores indicate higher levels of each type of regulation.

    Measured: Approximately every 13 weeks through study completion, expected to be 3 years.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Mar 2019
  2. Study start1 Jun 2019
  3. Primary completion19 Oct 2021
  4. Study completion15 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03874988
Sponsor's protocol ID
018-783
Acronym
GLB-SCI+
Status last verified
Oct 2025
First submitted
7 Feb 2019
Last updated
15 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: This project will generate data designed to study the feasibility, effectiveness, and usability of several weight-loss strategies in a sample of approximately 100 participants with spinal cord injury. These data will be submitted to Inter-university Consortium for Political and Social Research (ICPSR). ICPSR will make the research data from this project available to the broader social science research community. These files, in which direct and indirect identifiers have been removed to minimize disclosure risk, may be accessed directly through the ICPSR website. After depositing the data, the dissemination will be delayed for one year to allow for the principal investigator and collaborators to complete major manuscripts related to the data. ICPSR will accept responsibility for long-term preservation of the research data upon receipt of a signed deposit form.

Questions about this trial

What is this clinical trial studying?

A study testing Enhanced Self-Monitoring, GLB-SCI and GLB-SCI+ in people with Spinal Cord Injuries and Obesity, run by Baylor Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in weight (time frame: Approximately every 13 weeks through study completion, expected to be 3 years.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in